Search for: "George v. Parke-Davis" Results 21 - 40 of 75
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jul 2014, 5:08 am by INFORRM
Cartius v Atlantic Mobility, heard 19 June 2014 (HHJ Parkes QC) Bewry v. [read post]
7 Apr 2024, 4:37 pm by INFORRM
Newspaper Journalism and regulation IPSO Resolution Statement – 00019-24 Peach v dorset.live, 7 children in sex cases (2021), 12 Discrimination (2021), 1 Accuracy (2021), 2 Privacy (2021), 4 Intrusion into grief or shock (2021), 14 Confidential sources (2021), Resolved – IPSO mediation Resolution Statement – 00032-24 Hudson v The Mail on Sunday, 1 Accuracy (2021), Resolved – IPSO mediation 20825-23 Revell v The Mail on Sunday, 1 Accuracy (2021), No… [read post]
15 Apr 2024, 2:31 am by INFORRM
Reserved Judgments Harrison v Cameron, heard 26 March 2024 (Steyn J) BW Legal Services Limited v Trustpilot,  heard 7 March 2024 (HHJ Lewis) Unity Plus Healthcare Limited v Clay and others,  heard 1 March 2024 (HHJ Lewis) Parsons v Atkinson, heard 26 and 27 February 2024 (Farbey J) Vince v Associated Newspapers, heard 19 February 2024 (HHJ Lewis) Pacini v Dow Jones, heard 13 December 2023 (HHJ Parkes KC) Wilson… [read post]
4 Dec 2016, 4:08 pm by INFORRM
Last week in the Courts On 29 and 30 November and 1 December 2016 the Court of Appeal (Macfarlane, Davis and Sharp LJJ) heard the important “serious harm” appeal in the case of Lachaux v Independent Print. [read post]
4 Dec 2011, 4:04 pm by INFORRM
In RSPCA (NSW) v Davies [2011] NSWSC 1445, Latham J awarded the RSPCA in NSW damages of Aus$100,000 for defamatory material posted on a website authored by retired “forensic computer detective” Mal Davies. [read post]
23 Mar 2015, 12:42 am by INFORRM
On 18 March 2015, Nicola Davies J heard an application in the case of Lachaux v AOL Ltd. [read post]
17 Oct 2011, 1:46 am by INFORRM
Judgments The following reserved judgments after public hearings remain outstanding: WXY v Gewanter, heard 11-15, 18-19 July 2011 (Slade J) Commissioner of Police v Times Newspapers, heard 18-20 & 22 July 2011 (Tugendhat J) Morrison v Buckinghamshire CC, heard 20 to 21 July (HHJ Parkes QC) The Queen on the application of Guardian News and Media Limited -v- City of Westminster Magistrates’ Court heard 11 October 2011 (Master of the Rolls, Jackson… [read post]
6 May 2024, 4:43 am by INFORRM
Sir David Davis MP has tabled a number of far reaching amendments [pdf] to the  Strategic Litigation Against Public Participation Bill [pdf] which returns to the House of Commons for its Committee Stage on 8 May 2024. [read post]
23 Jan 2017, 1:25 am by INFORRM
On 20 January 2017, Sir Davie Eady heard applications in the case of Daryanani -v- Ramnani. [read post]
19 May 2024, 10:13 pm by INFORRM
As mentioned above, on the same day a statement in open court was read out in the case of Davies v BBC–KB-2024-000828. [read post]
12 Nov 2014, 8:01 am by Schachtman
United States, 320 U.S. 1, 60–61 (1943) (Frankfurter, J., dissenting in part) (‘‘it is an old observation that the training of Anglo–American judges ill fits them to discharge the duties cast upon them by patent legislation’’); ParkeDavis & Co. v. [read post]
25 Jun 2017, 4:11 pm by INFORRM
Nunziato, George Washington University Law School. [read post]
13 May 2024, 12:57 am by INFORRM
On Tuesday 14 May 2024 there will be an application for security for costs in the case of Sikhs for Justice and another v Ranger KB-2022-004490 and a statement in open court in the case of Davies -v- BBC–KB-2024-000828. [read post]
1 Jul 2012, 5:52 pm by INFORRM
The privacy trial in AAA v Associated Newspapers before Nicola Davies J concluded on 26 June 2012 after a six day trial. [read post]
18 Dec 2016, 4:19 pm by INFORRM
Lisle-Mainwaring v Associated Newspapers heard 11 November 2016 (HHJ Parkes QC). [read post]
23 Jun 2019, 4:25 pm by INFORRM
On 19 June 2019 HHJ Parkes QC heard an application in the case of BVC v EWF. [read post]
9 Jan 2012, 6:24 pm by FDABlog HPM
DILANTIN KAPSEALS (extended phenytoin sodium) Capsules, 100 mg, is a brand-name anti-epileptic drug product marketed by Pfizer’s Parke-Davis unit that FDA approved on August 27, 1976 under ANDA No. 084349 (presumably as a generic version of a pre-1962 drug under the pre-Hatch-Waxman ANDA approval procedures, based on the 80,000 series application number). [read post]